Report cover image

Anesthesia And Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Respiratory Devices, Anesthesia Devices), By Region (North America, Europe, Asia Pacific, Latin America), And Segment Forecasts, 2025 - 2033

Publisher Grand View Research
Published Oct 30, 2025
Length 250 Pages
SKU # GV20575216

Description

Anesthesia And Respiratory Devices Market Summary

The global anesthesia and respiratory devices market size was estimated at USD 56.3 billion in 2024 and is expected to reach USD 91.5 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The industry is driven by an increased incidence of respiratory disorders such as Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD), fast urbanization, an increase in surgical operations, pollution levels, a geriatric population, and a smoking population.

For instance, according to the Australian Institute of Health and Welfare, in 2023, COPD accounted for 50% of the total burden of disease due to respiratory conditions and 3.6% of the total disease burden. Furthermore, according to the American Lung Association, in 2022, 4.6% of adults, or 11.7 million people, reported a diagnosis of chronic bronchitis, COPD, or emphysema.

The rising population of smokers is also leading to the increasing incidence of respiratory diseases, such as emphysema, bronchitis, cancer, and other lung diseases, which is leading to the growing demand for respiratory devices, hence boosting the market growth. According to WHO data published in July 2023, tobacco use is responsible for over 8 million deaths annually worldwide. Of these, more than 7 million are attributed to direct tobacco consumption, while approximately 1.3 million are due to second-hand smoke exposure among non-smokers.

Global Anesthesia And Respiratory Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global anesthesia and respiratory devices market report based on product and region:
  • Product Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory Devices
  • Respiratory Equipment
  • Humidifiers
  • Heat Humidifiers
  • Heated Wire Breathing Circuits
  • Heat Exchangers
  • Pass Over Humidifiers
  • Nebulizers
  • Pneumatic Nebulizers
  • Mesh Nebulizers
  • Ultrasonic Nebulizers
  • Oxygen Concentrator
  • Fixed Oxygen Concentrators
  • Portable Oxygen Concentrators
  • Positive Airway Pressure Devices
  • Bilevel & automatic positive airway pressure devices
  • Continuous positive airway pressure devices
  • Reusable Resuscitators
  • Ventilators
  • Adult Ventilators
  • Neonatal Ventilators
  • Respiratory Inhalers
  • Dry Powdered Inhalers
  • Metered Dose Inhaler
  • Respiratory Disposables
  • Disposable Oxygen Masks
  • Resuscitators
  • Tracheostomy Tubes
  • Oxygen Cannula
  • Respiratory Measurement Devices
  • Pulse Oximetry systems
  • Capnographs
  • Spirometers
  • Peak Flowmeters
  • Anesthesia Devices
  • Anesthesia Machines
  • Anesthesia Workstation
  • Anesthesia delivery machines
  • Portable
  • Standalone
  • Anesthesia Ventilators
  • Anesthesia Monitors
  • Anesthesia Disposables
  • Anesthesia Masks
  • Anesthesia Accessories
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

250 Pages
Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product outlook
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope
3.1. Market Dynamics
3.1.1. Market driver analysis
3.1.1.1. Rise In Chronic Respiratory Diseases And Geriatric Population
3.1.1.2. Technological Advancements
3.1.1.3. Supportive Initiatives by Government and Private Organizations
3.1.2. Market Restraint analysis
3.1.2.1. Product Recalls & Failure
3.1.2.2. Complexity of Modern Anesthesia and Respiratory Machines
3.1.3. Market Opportunities
3.2. Anesthesia and Respiratory Devices Market Analysis Tools
3.2.1. Industry Analysis - Porter’s
3.2.1.1. Supplier power
3.2.1.2. Buyer power
3.2.1.3. Substitution threat
3.2.1.4. Threat of new entrant
3.2.1.5. Competitive rivalry
3.2.2. PESTEL Analysis
3.2.2.1. Political landscape
3.2.2.2. Economic landscape
3.2.2.3. Social landscape
3.2.2.4. Technological landscape
3.2.2.5. Environmental landscape
3.2.2.6. Legal landscape
Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis
4.1. Product Type Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Brain Computer Interface Market by Product Type Outlook
4.3.1. Anesthesia Devices
4.3.1.1. Anesthesia Devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1. Anesthesia Machines
4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.2. Anesthesia Workstation
4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3. Anesthesia Delivery Machines
4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3.2. Portable Anesthesia Delivery Machine
4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3.3. Standalone Anesthesia Delivery Machine
4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Machine market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.4. Anesthesia Ventilators
4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.5. Anesthesia Monitors
4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.2. Anesthesia Disposables
4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.2.2. Anesthesia Masks
4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.1.1.2.3. Anesthesia Accessories
4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2. Respiratory Devices
4.3.2.1. Respiratory devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1. Respiratory Equipment
4.3.2.1.1.1. Respiratory Equipment’s market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2. Humidifiers
4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.2. Heat Humidifiers
4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.3. Heated wire breathing circuits
4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.4. Heat Exchangers
4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.2.5. Pass Over Humidifiers
4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3. Nebulizers
4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3.2. Pneumatic nebulizers
4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3.3. Mesh nebulizers
4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.3.4. Ultrasonic nebulizers
4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.4. Oxygen Concentrators
4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.4.2. Fixed Oxygen Concentrators
4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.4.3. Portable Oxygen Concentrators
4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.5. Positive airway pressure devices
4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.5.2. Bi-level positive airway pressure devices
4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.5.3. Continuous positive airway pressure devices
4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.6. Reusable resuscitators
4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.7. Ventilators
4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.7.2. Adult Ventilators
4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.7.3. Neonatal Ventilators
4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.8. Respiratory inhalers
4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.8.2. Dry Powdered Inhalers
4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.8.3. Metered Dose Inhalers
4.3.2.1.1.8.3.1. Metered Dose Inhalers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9. Respiratory disposable
4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.2. Disposable Oxygen Mask
4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.3. Resuscitators
4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.4. Tracheostomy Tubes
4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.9.5. Oxygen Cannula
4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10. Respiratory measurement devices
4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.2. Pulse oximetry systems
4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.3. Capnographs
4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.4. Spirometers
4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2021 - 2033 (USD Million)
4.3.2.1.1.10.5. Peak flowmeters
4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product
5.1. Regional Market Share Analysis, 2024 & 2033
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. North America
5.4.1. U.S.
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Canada
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.4.3. Mexico
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Europe
5.5.1. UK
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Germany
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. France
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Italy
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
5.5.5. Spain
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
5.5.6. Norway
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
5.5.7. Sweden
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework/ reimbursement structure
5.5.8.3. Competitive scenario
5.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. China
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. India
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
5.6.4. Australia
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
5.6.6. Thailand
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. Argentina
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2. Saudi Arabia
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
5.8.3. UAE
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
5.8.4. Kuwait
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework/ reimbursement structure
5.8.4.3. Competitive scenario
5.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key company market share/position analysis, 2024
6.4. Company Profiles
6.4.1. Medtronic
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Teleflex Incorporated
6.4.2.1. Company Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Koninklijke Philips N.V.
6.4.3.1. Company Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Drägerwerk AG & Co. KGaA
6.4.4.1. Company Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Getinge AB.
6.4.5.1. Company Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Smiths Group plc
6.4.6.1. Company Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Fisher & Paykel Healthcare Limited.
6.4.7.1. Company Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Masimo
6.4.8.1. Company Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic initiatives
6.4.9. B. Braun Melsungen AG
6.4.9.1. Company Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic initiatives
6.4.10. ResMed
6.4.10.1. Company Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic initiatives
6.4.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
6.4.11.1. Company Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Strategic initiatives
6.4.12. Inogen, Inc.
6.4.12.1. Company Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Strategic initiatives
6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
6.4.13.1. Company Overview
6.4.13.2. Financial Performance
6.4.13.3. Product Benchmarking
6.4.13.4. Strategic initiatives
6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical).
6.4.14.1. Company Overview
6.4.14.2. Financial Performance
6.4.14.3. Product Benchmarking
6.4.14.4. Strategic initiatives
6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
6.4.15.1. Company Overview
6.4.15.2. Financial Performance
6.4.15.3. Product Benchmarking
6.4.15.4. Strategic initiatives
6.4.16. O2 Concepts
6.4.16.1. Company Overview
6.4.16.2. Financial Performance
6.4.16.3. Product Benchmarking
6.4.16.4. Strategic initiatives
6.4.17. Nidek Medical Products, Inc.
6.4.17.1. Company Overview
6.4.17.2. Financial Performance
6.4.17.3. Product Benchmarking
6.4.17.4. Strategic initiatives
6.4.18. Omron Corporation
6.4.18.1. Company Overview
6.4.18.2. Financial Performance
6.4.18.3. Product Benchmarking
6.4.18.4. Strategic initiatives
6.4.19. GE Healthcare
6.4.19.1. Company Overview
6.4.19.2. Financial Performance
6.4.19.3. Product Benchmarking
6.4.19.4. Strategic initiatives
6.4.20. Allied Healthcare
6.4.20.1. Company Overview
6.4.20.2. Financial Performance
6.4.20.3. Product Benchmarking
6.4.20.4. Strategic initiatives
6.4.21. Vectura Group Plc.
6.4.21.1. Company Overview
6.4.21.2. Financial Performance
6.4.21.3. Product Benchmarking
6.4.21.4. Strategic initiatives
6.4.22. PARI Respiratory Equipment, Inc.
6.4.22.1. Company Overview
6.4.22.2. Financial Performance
6.4.22.3. Product Benchmarking
6.4.22.4. Strategic initiatives
6.4.23. Aerogen
6.4.23.1. Company Overview
6.4.23.2. Financial Performance
6.4.23.3. Product Benchmarking
6.4.23.4. Strategic initiatives
6.4.24. Beurer
6.4.24.1. Company Overview
6.4.24.2. Financial Performance
6.4.24.3. Product Benchmarking
6.4.24.4. Strategic initiatives
6.4.25. Briggs Healthcare
6.4.25.1. Company Overview
6.4.25.2. Financial Performance
6.4.25.3. Product Benchmarking
6.4.25.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us